Promotion Pact Broadens Conceptus’ Market For Birth-Control Device
This article was originally published in The Gray Sheet
Executive Summary
Conceptus is redoubling efforts to sell non-incisional birth control to physician offices after failing to acquire Ovion
You may also be interested in...
Bayer Buys Essure Contraceptive-Maker Conceptus For $1.1 Billion
The acquisition will add a popular nonsurgical, permanent birth control device to Bayer’s line of contraceptive pharmaceuticals and women’s health products.
AMS May Enter Permanent Birth-Control Market Via Merger Or License
Conceptus has less than three weeks to decide whether to purchase Ovion or to allow the transcervical sterilization device developer to merge with American Medical Systems
Cosmetic And Personal Care Trademark Review: 9 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.